Shifting paradigms in the treatment of lower extremity vascular disease: A report of 1000 percutaneous interventions

Annals of Surgery

Volumn 246, Issue 3, 2007, Pages 415-422

  DeRubertis, Brian G ^a   Faries, Peter L ^a   McKinsey, James F ^a   Chaer, Rabih A ^a   Pierce, Matthew ^a   Karwowski, John ^a   Weinberg, Alan ^a   Nowygrod, Roman ^a   Morrissey, Nicholas J ^a   Bush, Harry L ^a   Kent, K Craig ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMPUTATION; ANGIOPLASTY; ARTICLE; ATHERECTOMY; BYPASS SURGERY; CHRONIC KIDNEY FAILURE; CLAUDICATION; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DIABETES MELLITUS; FEMALE; FEMORAL ARTERY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LASER ANGIOPLASTY; LEG; LEG BLOOD VESSEL; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PAIN; POPLITEAL ARTERY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECURRENT DISEASE; SMOKING; STENT; SURGICAL TECHNIQUE; TIBIAL ARTERY; VASCULAR DISEASE; VASCULAR PATENCY; VASCULAR SURGERY;

AGED; AMPUTATION; ANGIOGRAPHY; ANGIOPLASTY; ANTICOAGULANTS; ATHERECTOMY; COMORBIDITY; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; LIMB SALVAGE; MALE; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 34548189061     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31814699a2     Document Type: Article

References (44)

1. Hackam DG. Cardiovascular risk prevention in peripheral artery disease. J Vasc Surg. 2005;41:1070-1073.
2. Yeager RA, Moneta GL, Taylor LM Jr, et al. Surgical management of severe acute lower extremity ischemia. J Vasc Surg. 1992;15:385-391; discussion 392-393.
3. Hunink MG, Wong JB, Donaldson MC, et al. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA. 1995;274:165-171.
4. Garcia LA. Epidemiology and pathophysiology of lower extremity peripheral arterial disease. J Endovasc Ther. 2006;13:II3-II9.
5. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257-1264.
6. Schmieder FA, Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Cardiol. 2001;87:3D-13D.
7. Taylor SM, Kalbaugh CA, Blackhurst DW, et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg. 2006;44:747-755; discussion 755-756.
8. Lepantalo M, Matzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg. 1996;11:153-157.
9. Bertele V, Roncaglioni MC, Pangrazzi J, et al. Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group. Eur J Vasc Endovasc Surg. 1999;18:401-410.
10. Veith FJ, Ascer E, Gupta SK, et al. Tibiotibial vein bypass grafts: a new operation for limb salvage. J Vasc Surg. 1985;2:552-557.
11. Veith FJ, Moss CM, Daly V, et al. New approaches to limb salvage by extended extra-anatomic bypasses and prosthetic reconstructions to foot arteries. Surgery. 1978;84:764-774.
12. Sayers RD, Raptis S, Berce M, et al. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg. 1998;85:934-938.
13. Morgan JH III, Wall CE Jr, Christie DB, et al. The results of superficial femoral, popliteal, and tibial artery stenting for peripheral vascular occlusive disease. Am Surg. 2005;71:905-909; discussion 909-910.
14. Adam DJ, Beard JD, Cleveland T, et al; BASIL Trial Participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934.
15. Eskelinen E, Alback A, Roth WD, et al. Infra-inguinal percutaneous transluminal angioplasty for limb salvage: a retrospective analysis in a single center. Acta Radiol. 2005;46:155-162.
16. Black JH III, LaMuraglia GM, Kwolek CJ, et al. Contemporary results of angioplasty-based infrainguinal percutaneous interventions. J Vasc Surg. 2005;42:932-969.
17. Parsons RE, Suggs WD, Lee JJ, et al. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg. 1998;28:1066-1071.
18. Kudo T, Chandra FA, Kwun WH, et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg. 2006;44:304-313.
19. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg. 2005;41:423-435; discussion 435.
20. Clair DG, Dayal R, Faries PL, et al. Tibial angioplasty as an alternative strategy in patients with limb-threatening ischemia. Ann Vasc Surg. 2005;19:63-68.
21. Laird JR, Biamino G, McNamara T, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow-up results. J Endovasc Ther. 2006;13(suppl 2):II52-II59.
22. Yancey AE, Minion DJ, Rodriguez C, et al. Peripheral atherectomy in TransAtlantic intersociety consensus type C femoropopliteal lesions for limb salvage. J Vasc Surg. 2006;44:503-508.
23. Laird JR, Zeller T, Gray BH, et al; LACI Investigators. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006;13:1-11.
24. Klinkert P, Schepers A, Burger DH, et al. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37:149-155.
25. Zannetti S, L'Italien GJ, Cambria RP. Functional outcome after surgical treatment for intermittent claudication. J Vasc Surg. 1996;24:65-73.
26. Conte MS, Bandyk DF, Clowes AW, et al; PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742-751.
27. Klinkert P, van Dijk PJ, Breslau PJ. Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage. Ann Vasc Surg. 2003;17:486-491.
28. Goshima KR, Mills JL Sr, Hughes JD. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg. 2004;39:330-335.
29. Schepers A, Klinkert P, Vrancken Peeters MP, et al. Complication registration in patients after peripheral arterial bypass surgery. Ann Vasc Surg. 2003;7:198-202.
30. L'Italien GJ, Cambria RP, Cutler BS, et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg. 1995;21:935-944.
31. Gibbons GW, Burgess AM, Guadagnoli E, et al. Return to well-being and function after infrainguinal revascularization. J Vasc Surg. 1995;21:35-44; discussion 44-45.
32. Dosluoglu HH, Harris LM, Cherr GS. Recanalization of concomitant iliac artery and common femoral artery occlusions using an antegrade hybrid (open/endovascular) approach. Vasc Endovascular Surg. 2007;41:130-134.
33. Pavkov ML, Lermusiaux P, Bleuet FO, et al. Simultaneous ipsilateral infrainguinal angioplasty and bypass procedures. Vascular. 2007;15:30-34.
34. Conrad MF, Cambria RP, Stone DH, et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg. 2006;44:762-769.
35. Abbruzzese TA, Havens J, Belkin M, et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004;39:1178-1185.
36. Molloy KJ, Nasim A, London NJ, et al. Percutaneous transluminal angioplasty in the treatment of critical limb ischemia. J Endovasc Ther. 2003;10:298-303.
37. Surowiec SM, Davies MG, Eberly SW, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg. 2005;41:269-278.
38. Lofberg AM, Karacagil S, Ljungman C, et al. Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg. 2001;34:114-121.
39. Lazaris AM, Salas C, Tsiamis AC, et al. Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia. Eur J Vasc Endovasc Surg. 2006;32:668-674.
40. Smith BM, Stechman M, Gibson M, et al. Subintimal angioplasty for superficial femoral artery occlusion: poor patency in critical ischaemia. Ann R Coll Surg Engl. 2005;87:361-365.
41. Tefera G, Turnipseed W, Tanke T. Limb salvage angioplasty in poor surgical candidates. Vasc Endovascular Surg. 2003;37:99-104.
42. Clark TW, Groffsky JL, Soulen MC. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol. 2001;12:923-933.
43. Hewes RC, White RI Jr, Murray RR, et al. Long-term results of superficial femoral artery angioplasty. AJR Am J Roentgenol. 1986;146:1025-1029.
44. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg. 2000;31:S1-S296.